Latest Car T News

CAR Group has reported strong first-half results for FY26, with double-digit revenue and earnings growth across all key regions, underpinned by strategic AI investments and expanding market presence.

CAR Group Limited has announced a fully paid ordinary dividend of AUD 0.425 per share for the six months ending December 2025, accompanied by a Dividend Reinvestment Plan (DRP) with no discount.

CAR Group Limited reported a strong half-year result for the period ending 31 December 2025, with revenue up 8% and adjusted net profit rising 11.5%, driven by robust performance across Australia, North America, Latin America, and Asia.

Jumbo Interactive’s preliminary 1H26 results reveal robust double-digit growth driven by SaaS and Managed Services, despite a quieter jackpot landscape. The recent acquisitions in the UK and US add momentum but introduce new accounting complexities.

JAYRIDE Group Limited advances its transformation into a scalable Mobility-as-a-Service platform with a new SaaS agreement in Thailand, strategic partnerships, and a successful capital raise. The company tightens its cost base while preparing for ASX reinstatement.

CL8 Holdings has sharply reduced expenses following office closure and is actively exploring new growth sectors including AI, B2B SaaS, EdTech, and Cybersecurity while maintaining its stake in the expanding car subscription market.

Imugene Limited has reported compelling clinical trial results for its off-the-shelf CAR T therapy, azer-cel, alongside FDA validation and a strategic collaboration, while managing cash flow amid cost reductions.

Prescient Therapeutics has secured a key regulatory milestone with the EMA granting Orphan Drug Designation for PTX-100 to treat cutaneous T-cell lymphoma, while expanding its Phase 2a clinical trial across multiple continents.

AdAlta Limited has launched its 'East to West' cellular immunotherapy operations through a strategic collaboration with Shanghai Cell Therapy Group to co-develop BZDS1901, an innovative CAR-T therapy targeting mesothelioma and other solid cancers. The company also strengthened its balance sheet by raising $2.8 million via private placements and repaying key investment agreements.

Carma Limited has reported a surge in vehicle sales and revenue in its latest quarterly report, alongside a successful $100 million IPO that strengthens its growth trajectory.

European Metals Holdings has marked a pivotal quarter with the completion of a Definitive Feasibility Study for its Cinovec Lithium Project, securing a €360 million Czech government grant and submitting a key Environmental Impact Assessment, propelling the project closer to production.

MONEYME has reported a robust second quarter with a 26% increase in its loan book to $1.75 billion and a 19% rise in revenue to $60 million, underpinned by improved credit quality and strategic funding initiatives.